2023-06-12
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million
Viva successfully raised nearly US$ 150 million through the transfer of approximately 24% of its equity interest to Temasek, HLC, and True Light.
2023-05-20
ETANA HAS SECURED FINANCING FROM DEG, EAST VENTURES AND OTHER GLOBAL INVESTORS
Etana has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Venture.
2022-09-16
China's HighLight hits first close onlife sciences fund, targets $650m
HighLight Capital, a China-based life sciences investor, has completeda first close of USD 540m on its fourth US dollar-denominated fund.
2021-07-21
Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering
Imago a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms, announced IPO
2021-05-07
Singular Genomics Systems, a developer of next-gen sequencing tech, files for a $100 million IPO
Singular, which is developing novel next generation sequencing and multiomics technologies, filed with the SEC to raise up to $100M in an IPO
2019-11-28